Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1379)
  2. Journal Article (1159)
  3. Review (129)
  4. Editorial (65)
  5. Research Letter (36)
  6. Correspondence (26)
  7. Book Section (25)
  8. Guidelines (13)
  9. Conference Paper (2)
  10. Miscellaneous (2)
Groups
  1. Hematology-Oncology Fellows (2763)
  2. Department of Medicine (2720)
  3. Solid Tumor Oncology Division (2017)
  4. Hematologic Malignancies, Division of (1337)
  5. GSK Faculty (1233)
  6. Department of Pathology and Laboratory Medicine (988)

More Groups

People
  1. Michael Berger (220)
  2. Marc Ladanyi (198)
  3. Pedram Razavi (184)
  4. Michael Offin (177)
  5. Sergio Giralt (171)
  6. David Solit (169)

More People

Years
  1. 2025 (223)
  2. 2024 (414)
  3. 2023 (330)
  4. 2022 (377)
  5. 2021 (339)
  6. 2020 (323)

More Years

Publications
  1. Journal of Clinical Oncology (568)
  2. Blood (299)
  3. Annals of Oncology (107)
  4. Clinical Cancer Research (102)
  5. Journal of Thoracic Oncology (96)
  6. Cancer Research (87)

More Publications

Publishers
  1. American Society of Clinical Oncology (645)
  2. Elsevier Inc. (344)
  3. American Society of Hematology (339)
  4. American Association for Cancer Research (241)
  5. Nature Publishing Group (202)
  6. Oxford University Press (157)

More Publishers

Results (2836)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cell free DNA (cfDNA) assessment of esophagogastric (EG) cancer using MSK-ACCESS
    Meeting Abstract

    Cytryn, S. L.; Phu, W.; Shah, R. H.; Walch, H. S.; Chatila, W. K.; Vakiani, E.; Brannon, A. R.; Ladanyi, M.; Srivastava, A.; Tang, L. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • BRAF variants and oncogenic fusions to define sporadic MMR-deficient colorectal cancer subtypes
    Meeting Abstract

    Abdelfattah, S.; Harada, G.; Patel, S.; Artz, O.; Yaeger, R.; Johannet, P.; Harrold, E.; Walch, H. S.; Argiles, G.; Rousseau, B.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with metastatic colitis-associated cancer treated with EGFR inhibitors
    Meeting Abstract

    Yeh, C.; Cowley, C.; Srivastava, A.; Chatila, W. K.; Ismailgeci, D.; Chou, J. F.; Capanu, M.; Shah, M. A.; Sanchez-Vega, F.; Ganesh, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Node positive non-clear cell renal cell carcinoma: Oncological outcomes and genomic insights
    Meeting Abstract

    Eismann, L.; Zucker, M.; Dawidek, M.; Reese, S.; Posada Calderon, L.; Aulitzky, A.; Stief, C.; Coleman, J.; Kotecha, R.; Carlo, M.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • What is high-risk mantle cell lymphoma, and how should we treat it?
    Journal Article

    Epstein-Peterson, Z.; Kumar, A.
    Targeted Therapies in Oncology (2024)

    Fulltext@MSK | Save
  • Intratumoral escherichia is associated with improved survival to single-agent immune checkpoint inhibition in patients with advanced non–small-cell lung cancer
    Journal Article

    Elkrief, A.; Montesion, M.; Sivakumar, S.; Hale, C.; Bowman, A. S.; Begüm Bektaş, A.; Bradic, M.; Kang, W.; Chan, E.; Gogia, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • RET inhibitors in RET fusion-positive lung cancers: Past, present, and future
    Review

    Chen, M. F.; Repetto, M.; Wilhelm, C.; Drilon, A.
    Drugs (2024)

    Fulltext@MSK | Save
  • Aberrant pre-mRNA processing in cancer
    Review

    Biswas, J.; Boussi, L.; Stein, E.; Abdel-Wahab, O.
    Journal of Experimental Medicine (2024)

    Fulltext@MSK | Save
  • Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer
    Journal Article

    Tsimberidou, A. M.; Alayli, F. A.; Okrah, K.; Drakaki, A.; Khalil, D. N.; Kummar, S.; Khan, S. A.; Hodi, F. S.; Oh, D. Y.; Cabanski, C. R.; more...
    Journal of Experimental Medicine (2024)

    Fulltext@MSK | Save